From: PCA3 in prostate cancer and tumor aggressiveness detection on 407 high-risk patients: a National Cancer Institute experience
PCA3 score
≤51
>51
Gs ≤ 6 (%)
13 (31)
29 (69)
Gs ≥ 7 (%)
9 (12.5)
63 (87.5)